

In 2011, three behavioural economists at Harvard Business School and Duke University — Michael I. Norton, Daniel Mochon and Dan Ariely — conducted a series of laboratory experiments in which participants either folded an IKEA storage box themselves or evaluated a pre-assembled identical box. Without exception, the self-assemblers were willing to pay 63–73% more for the box they had personally built, even though the finished products were physically indistinguishable to outside judges. The authors published the finding in 2012 in the Journal of Consumer Psychology under a deliberately memorable title: “The IKEA Effect: When Labor Leads to Love.” The paper has since been cited more than 1,400 times and has quietly become one of the most consequential behavioural-finance ideas of the last two decades — particularly for retail investors who confuse the hours they spent on a stock with the quality of the stock itself.
For Indian long-term investors, the IKEA Effect is among the most expensive cognitive biases on Dalal Street, and almost nobody talks about it. It is the bias behind the WhatsApp-group investor who refuses to sell his 80% drawdown because “I studied this company for six months.” It is the bias behind the SIP investor who will not rebalance a clearly broken sectoral fund because she “spent two weekends picking it.” And it is the bias behind every Excel-modelling enthusiast who treats his own three-statement projection as a sacred valuation anchor rather than as one of many disposable hypotheses. Today’s post unpacks the original research, places it inside the Indian retail-investor context using SEBI and NSE data, and — per the day’s case-study mandate — closes with a dedicated illustrative look at how Titan Biotech Ltd (BSE: 524717) displays the corporate opposite of IKEA-Effect behaviour: a willingness to retire its own past decisions, audit its own narratives, and let the numbers, not the effort, do the talking.
Table of Contents
ToggleThe IKEA Effect is the systematic tendency to assign disproportionately higher value to objects, ideas, theses or portfolios that we have personally constructed, regardless of the quality of the final product. Norton, Mochon and Ariely demonstrated the effect across four pre-registered experiments using IKEA boxes, origami frogs and Lego sets. The results were robust:
The authors’ conclusion is summarised in one sentence in the original paper: “Labour alone can be sufficient to induce greater liking for the fruits of one’s labour: even constructing a standardised bureau, an arduous, solitary task, can lead people to overvalue their (often poorly-made) creations.” Translated into the language of the stock market: the hours you have personally poured into a stock thesis change how much you love it — but they do not change how much the market will eventually pay for it.
The IKEA Effect is not a single neural quirk; it is a stack of four well-documented psychological drivers operating together. Understanding the components is what allows long-term investors to dismantle it.
(a) Effort justification. Pioneered by Aronson & Mills (1959), this is the human tendency to inflate the value of any outcome that demanded effort, because we cannot tolerate the cognitive dissonance of having worked hard for something worthless. The 200-hour Excel model on a mid-cap pharma stock must be valuable — otherwise the 200 hours feel wasted.
(b) Endowment effect (Kahneman, Knetsch & Thaler, 1990). Once we possess an object — or once a thesis lives in our research folder — we treat it as ours, and ownership inflates valuation. The IKEA Effect strengthens the endowment effect because we are not merely owners; we are creators.

(c) Identity signalling. The Norton-Mochon-Ariely 2012 paper notes explicitly that self-built objects come to be seen as “an extension of the self.” In investing, the same dynamic explains why selling a stock you championed publicly feels like an admission of personal failure, not a portfolio decision.
(d) Sunk-cost reasoning. The hours invested in a thesis are economically gone — classic sunk costs — yet the brain refuses to treat them as sunk. Instead, it converts them into a phantom valuation floor. This is why the bias is most expensive in the small-cap and micro-cap segments, where retail investors typically spend the most research time.
India’s retail-investor base has grown from 4.9 crore demat accounts in March 2021 to over 19 crore by March 2026, according to depository data published by NSDL and CDSL. This is a 4x expansion in roughly five years. The newly-arrived cohort has consumed an unprecedented volume of self-directed research material — YouTube channels, screener-based stock-picking videos, Telegram groups, and Substack-style blog posts. Each retail investor today spends, on average, 5–9 hours per week on stock-related content (multiple investor-survey reports across 2024–2025). That weekly labour budget is exactly the raw material out of which the IKEA Effect is built.
The bias shows up in measurable, painful patterns in the Indian context:
Prof. V. Ravi Anshuman of IIM Bangalore, in his published lecture notes on Indian behavioural finance, observes that the Indian retail investor’s biggest behavioural penalty is not in stock selection, but in refusal to revise — a finding that maps cleanly onto Norton-Mochon-Ariely’s IKEA-Effect framework. Prof. Meir Statman’s 2017 work, Finance for Normal People, translates the same idea into the Indian context: the more an investor personally built a thesis, the less the market evidence is allowed to overrule it.
Once you accept that the bias exists, the antidote is process. The goal is to insert structural friction between the labour of research and the valuation of the result. Five practical disciplines, all suitable for a serious Indian long-term investor:
Benjamin Graham built the entire Mr. Market parable in The Intelligent Investor (1949) precisely to displace the investor’s own thesis with the market’s daily verdict. The framework is anti-IKEA by construction: the investor’s job is not to defend personal research, but to evaluate whether Mr. Market’s offer is more or less foolish than the underlying business case.

Warren Buffett has spoken repeatedly — at the 1998, 2003 and 2017 Berkshire Hathaway annual meetings — of the importance of being able to articulate the case against one’s own holdings. His phrasing in 2003: “If you cannot make the bear case for your own stock at least as well as the bull case, you do not own the stock; the stock owns you.” That sentence is, in spirit, a perfect description of the IKEA Effect.
Charlie Munger in his 1995 Harvard speech, “The Psychology of Human Misjudgment,” identified commitment and consistency tendency — the closest analogue to the IKEA Effect in his 25-bias taxonomy. His prescription, repeated across the 1995, 2000 and 2009 speeches, was the discipline of inversion: instead of asking “why is this thesis right?” ask “how could this thesis be lethally wrong?” The Munger antidote forces effort to be expended in opposition to the thesis, not in service of it.
Seth Klarman in Margin of Safety (1991) emphasises that a value-investing thesis “must be revisable without ego cost.” The Baupost Group’s internal process — documented in interviews with the firm’s analysts — requires analysts to write the “disqualifying memo” before the “buy memo”, which is the cleanest institutional antidote to the IKEA Effect ever publicly disclosed.
This section is an educational case study of management process. It is explicitly not a valuation call, not a buy/sell recommendation, and not a price target. No comment is offered on whether the stock is cheap or expensive at any price. The discussion focuses entirely on disclosed governance and capital-allocation behaviour as illustrative of the day’s behavioural lesson.
The IKEA Effect at the corporate level shows up in three forms: (i) management’s refusal to retire its own past projects; (ii) management’s preference for narrative over numbers in disclosure; and (iii) management’s reluctance to subject its own decisions to external review. The audited FY25 financials of Titan Biotech Ltd — a 35-year-old specialty-biotech house listed on the BSE with a market capitalisation of ₹1,779 crore at ₹430 per share as of 15 April 2026 — provide a useful illustrative mirror-image. The numbers below come from the FY25 Annual Report, consolidated financials, and Screener.in.
| Anti-IKEA-Effect Marker | Audited FY25 Number | Behavioural Interpretation |
|---|---|---|
| Borrowings (FY21 → FY25) | ₹16 Cr → ₹3 Cr (−81%) | Management retired a capital structure it once chose — the corporate opposite of being attached to one’s own past balance-sheet design. |
| CWIP cycling (FY23 peak → Sep 2025) | ₹13 Cr → ₹4 Cr | Capex projects are completed and pushed to gross block rather than allowed to sit indefinitely as half-built creations — the IKEA-Effect would keep them in CWIP forever. |
| Independent directors on board | 4 of 11 (36.4%) · Independent Chair | External, structurally non-aligned reviewers override the executive’s commitment to its own theses; meets the “disqualifying memo” spirit Klarman describes. |
| Board meetings in FY25 | 14 | High meeting frequency forces management theses to be re-defended on numbers every ~25 days — the corporate analogue of the time-decay scoring discipline above. |
| CFO / Operating Profit ratio (FY25) | 103% (FY24: 85%, FY23: 97%) | Cash arrives as the narrative claims — management is not inflating self-built accruals; the audit trail catches up with the story. |
| Contingent liabilities (FY25) | ₹7.78 Cr, −39.7% YoY; 5.08% of net worth | Liabilities the management did not hide reduced sharply — willingness to disclose downsides is the disclosure-side opposite of the IKEA Effect. |
| 10-year Sales / Profit CAGR | 15% / 29% | Profit CAGR is roughly 2x sales CAGR — suggests operating discipline rather than top-line vanity; numbers, not effort, are doing the work. |
| Quarterly revenue cadence (FY26 Q1 → Q3) | ₹46.50 Cr → ₹54 Cr → ₹56 Cr | Three consecutive QoQ increases — the recent operating record validates, rather than contradicts, the disclosed business model. |
| Domestic / Overseas segment mix | ₹10,254.80 lakh / ₹5,390.28 lakh (~34.5% exports) | Segmental disclosure splits the business externally, allowing investors to challenge management’s preferred internal narrative with their own slicing. |
What the table illustrates, taken together, is a management process that systematically inserts external friction between its own labour and its valuation of that labour — the exact opposite of the IKEA-Effect mechanism. The borrowings reduction shows willingness to abandon a previously chosen capital structure. The CWIP cycling shows willingness to push projects out of the “personally built” basket and into the depreciation schedule. The independent-director count and board meeting cadence show willingness to subject every internal thesis to external review every few weeks. The 103% CFO/Operating Profit ratio shows that the cash actually arrives in the form the narrative predicted. None of this is a comment on the stock at any price; it is a comment on the disclosed process. Investors evaluating their own behavioural exposure to the IKEA Effect may find Titan Biotech’s audited governance architecture a useful reference case to study.
Once again — and this point is emphasised because it matters: the section above is a behavioural case study only. It is not a research report, not investment advice, not a buy/sell/hold recommendation, and not a valuation verdict on Titan Biotech Ltd at any price. Investors are requested to consult their SEBI-registered investment advisor and conduct independent due diligence.
— Manish Goel / SEBI Registered Investment Advisor (INA100007736)
